Insilico Medicine Reports Benchmarks for its AI-Designed Therapeutics
Insilico Medicine has released benchmarks detailing the timelines and development metrics for 22 preclinical candidate (PCC) nominations achieved between 2021 …
News
AI for Protein Design: DeepMind Alum’s Startup Comes Out of Stealth with $50M
Latent Labs, a company developing AI models for computational protein design, has raised $50 million in funding and announced its …
Receptor.AI and Moexa Harness AI for SMAD3-Targeted Oncology and Fibrosis
Receptor.AI and Moexa Pharmaceuticals Limited have announced a partnership to accelerate the development of Moexa’s SMAD3 inhibitors for cancer and …
Basetwo Raises $11.5M for AI-Driven, First-Principles Pharmaceutical Manufacturing Optimization
Basetwo, an AI platform for manufacturing engineers, has raised $11.5 million in Series A funding. The funding will support the …
Insilico Medicine Doses First Patient With AI-Designed Pan-TEAD Inhibitor
Insilico Medicine, a clinical-stage biotechnology company leveraging generative AI for drug discovery, has dosed the first patient in its global …
Advarra Launches Study Collaboration Solution to Accelerate Clinical Trial Startup
Advarra, a provider of regulatory review solutions and clinical research technology, has introduced its Study Collaboration solution, designed to streamline …
RyboDyn Uncovers Dark Proteome, Secures $4M Pre-Seed for Cancer Immunotherapy
RyboDyn, a biotechnology company targeting the “dark proteome,” has announced the discovery of a previously hidden human proteome and closed …
Icelandic Biotech Raises €26.5M for Clinical-Stage Dementia and Skin Disease Treatments
Arctic Therapeutics (ATx), an Icelandic drug discovery and development company, has closed an oversubscribed €26.5 million Series A financing round. …
Tempus Announces National Launch of AI-Powered Personal Health Assistant
Tempus AI, Inc. (NASDAQ: TEM) has launched olivia, an AI-enabled app designed to help patients organize and manage their health …
Study: Trust in Scientists Post-Pandemic Remains High, but Public Wants More Engagement
Led by researchers from Harvard University, ETH Zurich, and the University of Zurich, a recent international study sheds light on …
Mayo Clinic Partners with Microsoft and Cerebras on Radiology and Genomics Foundation Models
Mayo Clinic has announced collaborations with Microsoft Research and Cerebras Systems to explore the potential of generative artificial intelligence (AI) …
Longevity Company Rubedo Announces Phase 1 Trials for GPX4 Modulator Targeting Aging Cells and Surrounding Tissues
Rubedo Life Sciences has unveiled its clinical development plans for RLS-1496, a first-in-class GPX4 modulator, during the 12th Annual Dermatology …